Neoanhydropodophyllol |
| Katalog-Nr.GC61120 |
Neoanhydropodophyllol ist ein Cyclolignan-Derivat mit antineoplastischer AktivitÄt. Neoanhydropodophyllol zeigt ZytotoxizitÄt gegenÜber mehreren Krebszellen (LeukÄmie, Lungenkarzinom und Dickdarmkarzinom).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 62287-47-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Neoanhydropodophyllol is a cyclolignan derivative, with antineoplastic activity. Neoanhydropodophyllol displays cytotoxicity against several cancer cells (leukemia, lung carcinoma, colon carcinoma)[1].
[1]. M Gordaliza, et al. Cytotoxic cyclolignans related to podophyllotoxin. Farmaco. 2001 Apr;56(4):297-304.
Average Rating: 5 (Based on Reviews and 5 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *